Blocking the P2X7 receptor improves outcomes after axonal fusion.

Rodriguez-Feo CL, Sexton KW, Boyer RB, Pollins AC, Cardwell NL, Nanney LB, Shack RB, Mikesh MA, McGill CH, Driscoll CW, Bittner GD, Thayer WP
J Surg Res. 2013 184 (1): 705-13

PMID: 23731685 · PMCID: PMC3759537 · DOI:10.1016/j.jss.2013.04.082

MeSH Terms (20)

Action Potentials Adenosine Triphosphate Animals Axons Benzenesulfonates Coloring Agents Drug Carriers Male Motor Activity Nerve Regeneration Neurosurgical Procedures Platelet Aggregation Inhibitors Polyethylene Glycols Purinergic P2X Receptor Antagonists Rats Rats, Sprague-Dawley Receptors, Purinergic P2X7 Sciatic Neuropathy Wallerian Degeneration Wound Healing

Connections (1)

This publication is referenced by other Labnodes entities:

Links